{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T01:28:26Z","timestamp":1791077306386,"version":"4.1.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,1,5]],"date-time":"2013-01-05T00:00:00Z","timestamp":1357344000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1007\/s15010-012-0387-6","type":"journal-article","created":{"date-parts":[[2013,1,4]],"date-time":"2013-01-04T13:13:28Z","timestamp":1357305208000},"page":"669-673","source":"Crossref","is-referenced-by-count":36,"title":["Ciprofloxacin reduces the risk of hemolytic uremic syndrome in patients with Escherichia coli O104:H4-associated diarrhea"],"prefix":"10.1007","volume":"41","author":[{"given":"H. F.","family":"Geerdes-Fenge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"L\u00f6bermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"N\u00fcrnberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Fritzsche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Koball","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Henschel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"H\u00f6hn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. C.","family":"Schober","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Mitzner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Podbielski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. C.","family":"Reisinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,1,5]]},"reference":[{"key":"387_CR1","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1056\/NEJMoa1106483","volume":"365","author":"C Frank","year":"2011","unstructured":"Frank C, Werber D, Cramer JP, et al. Epidemic profile of Shiga-toxin\u2013producing Escherichia coli O104:H4 outbreak in Germany. N Engl J Med. 2011;365:1771\u201380.","journal-title":"N Engl J Med"},{"key":"387_CR2","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1056\/NEJM200006293422601","volume":"342","author":"CS Wong","year":"2000","unstructured":"Wong CS, Jelacic S, Habeeb RL, Watkins SL, Tarr PI. The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. N Engl J Med. 2000;342:1930\u20136.","journal-title":"N Engl J Med"},{"key":"387_CR3","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1001\/jama.288.8.996","volume":"288","author":"N Safdar","year":"2002","unstructured":"Safdar N, Said A, Gangnon RE, Maki DG. Risk of hemolytic uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 enteritis. A meta-analysis. JAMA. 2002;288:996\u20131001.","journal-title":"JAMA"},{"key":"387_CR4","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1136\/bmj.330.7488.409","volume":"330","author":"B Phillips","year":"2005","unstructured":"Phillips B, Tyerman K, Whiteley SM. Use of antibiotics in suspected haemolytic-uraemic syndrome\u2014evidence based case report. Br Med J. 2005;330:409\u201310.","journal-title":"Br Med J"},{"key":"387_CR5","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/j.1365-2036.2006.03036.x","volume":"24","author":"GZ Panos","year":"2006","unstructured":"Panos GZ, Betsi GI, Falagas ME. Systematic review: are antibiotics detrimental or beneficial for the treatment of patients with Escherichia coli O157:H7 infection? Aliment Pharmacol Ther. 2006;24:731\u201342.","journal-title":"Aliment Pharmacol Ther"},{"key":"387_CR6","unstructured":"Robert Koch Institute (RKI). Available at: http:\/\/www.rki.de\/DE\/Content\/InfAZ\/E\/EHEC\/Falldefinition.pdf ."},{"key":"387_CR7","unstructured":"Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing: 21st informational supplement. Approved standard CLSI document M100-S21. CLSI, Wayne, 2011."},{"key":"387_CR8","doi-asserted-by":"crossref","first-page":"e4565","DOI":"10.1136\/bmj.e4565","volume":"345","author":"J Menne","year":"2012","unstructured":"Menne J, Nitschke M, Stingele R, et al. Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study. Br Med J. 2012;345:e4565.","journal-title":"Br Med J"},{"key":"387_CR9","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1093\/cid\/cis196","volume":"54","author":"A Rosales","year":"2012","unstructured":"Rosales A, Hofer J, Zimmerhackl LB, et al. Need for long-term follow-up in enterohemorrhagic Escherichia coli-associated hemolytic uremic syndrome due to late-emerging sequelae. Clin Infect Dis. 2012;54:1413\u201321.","journal-title":"Clin Infect Dis"},{"key":"387_CR10","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/cid\/cis299","volume":"55","author":"CS Wong","year":"2012","unstructured":"Wong CS, Mooney JC, Brandt JR, Staples AO, Jelacic S, Boster DR, Watkins SL, Tarr PI. Risk factors for the hemolytic uremic syndrome in children infected with Escherichia coli O157:H7: a multivariable analysis. Clin Infect Dis. 2012;55:33\u201341.","journal-title":"Clin Infect Dis"},{"key":"387_CR11","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/INF.0b013e31823096a8","volume":"31","author":"KE Smith","year":"2012","unstructured":"Smith KE, Wilker PR, Reiter PL, Hedican EB, Bender JB, Hedberg CW. Antibiotic treatment of Escherichia coli O157 infection and the risk of hemolytic uremic syndrome, Minnesota. Pediatr Infect Dis J. 2012;31:37\u201341.","journal-title":"Pediatr Infect Dis J"},{"key":"387_CR12","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/BF01704889","volume":"20","author":"JN Walterspiel","year":"1992","unstructured":"Walterspiel JN, Ashkenazi S, Morrow AL, Cleary TG. Effect of subinhibitory concentrations of antibiotics on extracellular Shiga-like toxin I. Infection. 1992;20:25\u20139.","journal-title":"Infection"},{"key":"387_CR13","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1128\/AAC.06315-11","volume":"56","author":"M Bielaszewska","year":"2012","unstructured":"Bielaszewska M, Idelevich EA, Zhang W, Bauwens A, Schaumburg F, Mellmann A, Peters G, Karch H. Epidemic Escherichia coli O104:H4: effects of antibiotics on Shiga toxin 2 production and bacteriophage induction. Antimicrob Agents Chemother. 2012;56:3277\u201382.","journal-title":"Antimicrob Agents Chemother"},{"key":"387_CR14","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.1128\/AAC.47.12.3789-3794.2003","volume":"47","author":"FM Wagenlehner","year":"2003","unstructured":"Wagenlehner FM, Wydra S, Onda H, Kinzig-Schippers M, S\u00f6rgel F, Naber KG. Concentrations in plasma, urinary excretion, and bactericidal activity of linezolid (600 milligrams) versus those of ciprofloxacin (500 milligrams) in healthy volunteers receiving a single oral dose. Antimicrob Agents Chemother. 2003;47:3789\u201394.","journal-title":"Antimicrob Agents Chemother"},{"key":"387_CR15","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1348-0421.2000.tb01251.x","volume":"44","author":"E Isogai","year":"2000","unstructured":"Isogai E, Isogai H, Hayashi S, Kubota T, Kimura K, Fujii N, Ohtani T, Sato K. Effect of antibiotics, levofloxacin and fosfomycin, on a mouse model with Escherichia coli O157 infection. Microbiol Immunol. 2000;44:89\u201395.","journal-title":"Microbiol Immunol"},{"key":"387_CR16","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1046\/j.1442-200X.1999.4121038.x","volume":"41","author":"M Shiomi","year":"1999","unstructured":"Shiomi M, Togawa M, Fujita K, Murata R. Effect of early oral fluoroquinolones in hemorrhagic colitis due to Escherichia coli O157:H7. Pediatr Int. 1999;41:228\u201332.","journal-title":"Pediatr Int"},{"key":"387_CR17","doi-asserted-by":"crossref","unstructured":"Borgatta B, Kmet-Luna\u010dek N, Rello J. E. coli O104:H4 outbreak and haemolytic-uraemic syndrome. Med Intensiva. 2012. doi: 10.1016\/j.medin.2011.11.022 .","DOI":"10.1016\/j.medin.2011.11.022"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-012-0387-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s15010-012-0387-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-012-0387-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T17:38:03Z","timestamp":1559497083000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s15010-012-0387-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,5]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["387"],"URL":"https:\/\/doi.org\/10.1007\/s15010-012-0387-6","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,5]]}}}